Signios Biosciences
Signios Biosciences offers a B2B software platform for multi-omics data analysis that turns complex genomic, transcriptomic, proteomic, and metabolomic data into actionable insights. It uses an AI-powered bioinformatics platform to integrate multi-omics data, uncovering patterns across studies and accelerating therapy development. As an affiliate of MedGenome, it leverages real-world evidence from large genomic and clinical datasets to inform research. The solution supports scalable, advanced analyses, including single-cell and spatial analysis, for life sciences and biotech customers. Signios targets precision medicine across oncology, neurology, autoimmune diseases, and rare disorders, aiming to speed the development of effective treatments.
Signios Biosciences
Signios Biosciences offers a B2B software platform for multi-omics data analysis that turns complex genomic, transcriptomic, proteomic, and metabolomic data into actionable insights. It uses an AI-powered bioinformatics platform to integrate multi-omics data, uncovering patterns across studies and accelerating therapy development. As an affiliate of MedGenome, it leverages real-world evidence from large genomic and clinical datasets to inform research. The solution supports scalable, advanced analyses, including single-cell and spatial analysis, for life sciences and biotech customers. Signios targets precision medicine across oncology, neurology, autoimmune diseases, and rare disorders, aiming to speed the development of effective treatments.